1-anilino-8-naphthalenesulfonate has been researched along with Heart Failure in 17 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Excerpt | Relevance | Reference |
---|---|---|
"Dark red nodules that drained an opaque amber liquid developed on the extensor surfaces of both legs in a 69-year-old woman receiving furosemide and spironolactone for congestive heart failure." | 3.65 | Panniculitis of the legs with urate crystal deposition. ( Niemi, KM, 1977) |
"To induce a pathological type of cardiac hypertrophy we infused angiotensin II (AngII) for 2 days via osmotic mini pumps in control and tamoxifen-inducible, cardiomyocyte (CM)-specific p38 MAPKα KO mice (iCMp38αKO) and assessed cardiac function by echocardiography, complemented by transcriptomic, histological, and immune cell analysis." | 1.72 | Cardiomyocyte p38 MAPKα suppresses a heart-adipose tissue-neutrophil crosstalk in heart failure development. ( Bottermann, K; Deenen, R; Fischer, JW; Gödecke, A; Grandoch, M; Harris, TE; Hemmers, A; Herebian, D; Kalfhues, L; Köhrer, K; Leitner, LM; Nederlof, R; Nemmer, J; Oenarto, V; Petzsch, P; Pfeffer, M; Raje, V; Reichert, AS; Stegbauer, J; Zabri, H, 2022) |
"Atglistatin treatment led to a dramatic reduction of these pro-fibrotic and pro-apoptotic processes." | 1.72 | Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage. ( Bartolomaeus, H; Beyhoff, N; Breinbauer, R; Foryst-Ludwig, A; Grabner, GF; Grune, J; Kershaw, EE; Kintscher, U; Klopfleisch, R; Luettges, K; Migglautsch, AK; Ritter, D; Rothe, M; Schupp, M; Smeir, E; Steinhoff, JS; Thiele, A; Wilck, N; Zechner, R, 2022) |
"Pressure overload-induced cardiac hypertrophy was generated in endothelial lipase(-/-) and wild-type mice by ascending aortic banding." | 1.39 | Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake. ( Hara, T; Hirata, K; Ishida, T; Kawai, H; Mori, K; Nakajima, H; Sasaki, N; Satomi-Kobayashi, S; Tanaka, H; Toh, R; Yasuda, T, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (23.53) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (11.76) | 29.6817 |
2010's | 9 (52.94) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Bottermann, K | 1 |
Kalfhues, L | 1 |
Nederlof, R | 1 |
Hemmers, A | 1 |
Leitner, LM | 1 |
Oenarto, V | 1 |
Nemmer, J | 1 |
Pfeffer, M | 1 |
Raje, V | 1 |
Deenen, R | 1 |
Petzsch, P | 1 |
Zabri, H | 1 |
Köhrer, K | 1 |
Reichert, AS | 1 |
Grandoch, M | 1 |
Fischer, JW | 1 |
Herebian, D | 1 |
Stegbauer, J | 1 |
Harris, TE | 1 |
Gödecke, A | 1 |
Thiele, A | 1 |
Luettges, K | 1 |
Ritter, D | 1 |
Beyhoff, N | 2 |
Smeir, E | 2 |
Grune, J | 2 |
Steinhoff, JS | 1 |
Schupp, M | 1 |
Klopfleisch, R | 2 |
Rothe, M | 2 |
Wilck, N | 1 |
Bartolomaeus, H | 1 |
Migglautsch, AK | 2 |
Breinbauer, R | 2 |
Kershaw, EE | 3 |
Grabner, GF | 1 |
Zechner, R | 4 |
Kintscher, U | 2 |
Foryst-Ludwig, A | 2 |
Potočnjak, I | 1 |
Trbušić, M | 1 |
Terešak, SD | 1 |
Radulović, B | 1 |
Pregartner, G | 1 |
Berghold, A | 1 |
Tiran, B | 1 |
Marsche, G | 1 |
Degoricija, V | 1 |
Frank, S | 1 |
Salatzki, J | 1 |
Bentele, K | 1 |
Blumrich, A | 1 |
Ban, Z | 1 |
Brix, S | 1 |
Dunst, S | 1 |
Surma, MA | 1 |
Klose, C | 1 |
Heinzel, FR | 1 |
Krannich, A | 1 |
Beule, D | 1 |
Schulze, PC | 1 |
Marx, N | 1 |
Parajuli, N | 1 |
Takahara, S | 1 |
Matsumura, N | 1 |
Kim, TT | 1 |
Ferdaoussi, M | 1 |
Dyck, JRB | 1 |
Zhou, H | 1 |
Lei, X | 1 |
Yan, Y | 1 |
Lydic, T | 1 |
Li, J | 1 |
Weintraub, NL | 1 |
Su, H | 1 |
Chen, W | 1 |
Nakajima, H | 1 |
Ishida, T | 1 |
Satomi-Kobayashi, S | 1 |
Mori, K | 1 |
Hara, T | 1 |
Sasaki, N | 1 |
Yasuda, T | 1 |
Toh, R | 1 |
Tanaka, H | 1 |
Kawai, H | 1 |
Hirata, K | 1 |
Schlueter, N | 1 |
Birkenfeld, AL | 1 |
Schrammel, A | 1 |
Mussbacher, M | 1 |
Wölkart, G | 1 |
Stessel, H | 1 |
Pail, K | 1 |
Winkler, S | 1 |
Schweiger, M | 1 |
Haemmerle, G | 2 |
Al Zoughbi, W | 1 |
Höfler, G | 1 |
Lametschwandtner, A | 1 |
Mayer, B | 1 |
Han, D | 1 |
Choi, R | 1 |
Hyun, C | 1 |
Higashi, M | 1 |
Hirano, K | 2 |
Kobayashi, K | 2 |
Ikeda, Y | 2 |
Issiki, A | 1 |
Otsuka, T | 1 |
Suzuki, A | 1 |
Yamaguchi, S | 1 |
Zaima, N | 2 |
Hamada, S | 1 |
Hanada, H | 1 |
Suzuki, C | 1 |
Nakamura, H | 1 |
Nagasaka, H | 1 |
Miyata, T | 1 |
Miyamoto, Y | 1 |
Naito, H | 1 |
Toda, T | 1 |
Sakata, Y | 1 |
Matsumiya, G | 1 |
RAO, R | 1 |
CHITRA, DR | 1 |
LAKSHMINARAYANA, G | 1 |
Lass, A | 1 |
Zimmermann, R | 1 |
Gorkiewicz, G | 1 |
Meyer, C | 1 |
Rozman, J | 1 |
Heldmaier, G | 1 |
Maier, R | 1 |
Theussl, C | 1 |
Eder, S | 1 |
Kratky, D | 1 |
Wagner, EF | 1 |
Klingenspor, M | 1 |
Hoefler, G | 1 |
Niemi, KM | 1 |
Gostomzyk, JG | 1 |
Frei, GF | 1 |
Vinci, GW | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Metabolic Signalling in Muscle- and Adipose Tissue Following Insulin Withdrawal and Growth Hormone Injection in Type I Diabetes Mellitus, a Clinical Experimental Study.[NCT02077348] | 9 participants (Actual) | Interventional | 2014-05-31 | Completed | |||
The Role of ATGL and G0/G1 Switch Gene Complex in Lipopolysaccaride (LPS) Induced Ketosis - a Controlled, Randomised, Clinical Experimental Study[NCT02157155] | 9 participants (Actual) | Interventional | 2014-06-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
17 other studies available for 1-anilino-8-naphthalenesulfonate and Heart Failure
Article | Year |
---|---|
Cardiomyocyte p38 MAPKα suppresses a heart-adipose tissue-neutrophil crosstalk in heart failure development.
Topics: Adipose Tissue; Angiotensin II; Animals; Cardiomegaly; Fatty Acids; Heart Failure; Inflammation; Lip | 2022 |
Pharmacological inhibition of adipose tissue adipose triglyceride lipase by Atglistatin prevents catecholamine-induced myocardial damage.
Topics: Adipose Tissue; Adrenergic Agents; Animals; Catecholamines; Heart Failure; Lipase; Lipolysis; Male; | 2022 |
Metabolic Syndrome Modulates Association between Endothelial Lipase and Lipid/Lipoprotein Plasma Levels in Acute Heart Failure Patients.
Topics: Aged; Aged, 80 and over; Female; Heart Failure; Humans; Lipase; Lipids; Lipoproteins; Male; Metaboli | 2017 |
Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
Topics: Adipose Tissue; Animals; Case-Control Studies; Cells, Cultured; Heart Failure; Humans; Hypertension; | 2018 |
Atglistatin ameliorates functional decline in heart failure via adipocyte-specific inhibition of adipose triglyceride lipase.
Topics: Adipocytes; Animals; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Heart Failure; | 2018 |
Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
Topics: Adipocytes; Adipose Tissue; Animals; Cardiomyopathies; Cell Differentiation; Disease Models, Animal; | 2019 |
Endothelial lipase modulates pressure overload-induced heart failure through alternative pathway for fatty acid uptake.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Disease Models, Anim | 2013 |
How high-density lipoprotein fuels the failing heart.
Topics: Animals; Blood Pressure; Fatty Acids; Heart Failure; Hypertension; Lipase; Signal Transduction | 2013 |
Endothelial dysfunction in adipose triglyceride lipase deficiency.
Topics: Adipose Tissue; Animals; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Heart Fail | 2014 |
Canine pancreatic-specific lipase concentrations in dogs with heart failure and chronic mitral valvular insufficiency.
Topics: Animals; Case-Control Studies; Dog Diseases; Dogs; Heart Failure; Lipase; Mitral Valve Insufficiency | 2015 |
Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase.
Topics: Cardiomyopathy, Dilated; Female; Heart Failure; Homozygote; Humans; Japan; Lipase; Male; Mutation; P | 2015 |
Triglyceride deposit cardiomyovasculopathy.
Topics: Adult; Biopsy; Cholesterol; Coronary Vessels; Heart Failure; Humans; Lipase; Male; Muscle, Skeletal; | 2008 |
SERUM TRIBUTYRINASE LEVELS IN HEALTH AND DISEASE.
Topics: Anemia; Anemia, Macrocytic; Clinical Enzyme Tests; Diabetes Mellitus; Dyspepsia; Female; Glomerulone | 1963 |
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Carboxylic Ester Hydrolas | 2006 |
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Carboxylic Ester Hydrolas | 2006 |
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Carboxylic Ester Hydrolas | 2006 |
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Carboxylic Ester Hydrolas | 2006 |
Panniculitis of the legs with urate crystal deposition.
Topics: Aged; Arthritis; Diagnosis, Differential; Female; Furosemide; Gout; Heart Failure; Humans; Lipase; S | 1977 |
[Unesterified free fatty acids in the serum and agonal circulatory failure].
Topics: Adenylyl Cyclases; Asphyxia; Catecholamines; Cholesterol; Craniocerebral Trauma; Fatty Acids; Fatty | 1970 |
[Lipase activity in the normal and pathological placenta (biochemical determination of placental lipase)].
Topics: Adult; Erythroblastosis, Fetal; Female; Heart Failure; Humans; Kidney Diseases; Lipase; Placenta; Pr | 1967 |